Contineum prices biotech's latest IPO, raising $110M for neuroinflammatory drugs
BioPharma
William Blair Inception Sciences Bristol Myers Squibb Contineum Therapeutics Biopharma Dive Myers Squibb
Source: biopharmadive.com
📰 Inception Sciences News
Inception Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Inception Sciences. Real-time updates on events, politics, business and more.
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination
Significance Statement Several reports have described glomerular disease relapse after coronaviru
United Kingdom Novartis Inception Sciences University Of British Columbia Institute Inc British Columbia Supplemental Table
Source: asnjournals.org